Integrated molecular drivers coordinate biological and clinical states in melanoma
- 23 November 2020
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 52 (12) , 1373-1383
Abstract
We performed harmonized molecular and clinical analysis on 1,048 melanomas and discovered markedly different global genomic properties among subtypes (BRAF, (N)RAS, NF1, triple wild-type (TWT)), subtype-specific preferences for secondary driver genes and active mutational processes previously unreported in melanoma. Secondary driver genes significantly enriched in specific subtypes reflected preferential dysregulation of additional pathways, such as induction of transforming growth factor-β signaling in BRAF melanomas and inactivation of the SWI/SNF complex in (N)RAS melanomas, and select co-mutation patterns coordinated selective response to immune checkpoint blockade. We also defined the mutational landscape of TWT melanomas and revealed enrichment of DNA-repair-defect signatures in this subtype, which were associated with transcriptional downregulation of key DNA-repair genes, and may revive previously discarded or currently unconsidered therapeutic modalities for genomically stratified melanoma patient subsets. Broadly, harmonized meta-analysis of melanoma whole exomes revealed distinct molecular drivers that may point to multiple opportunities for biological and therapeutic investigation.Keywords
Funding Information
- Damon Runyon Cancer Research Foundation (Damon Runyon Clinical Investigator Award)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R21CA242861, R01CA227388-02, F31CA239347)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- Amazon Web Services (AWS Cloud Credits for Research Program)
- U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (5T32HG002295-15)
- Claudia Adams Barr Program for Innovative Cancer Research
This publication has 98 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancerBritish Journal of Cancer, 2012
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanomaNature Genetics, 2012
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairsBioinformatics, 2012
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- The Ras-association domain family (RASSF) members and their role in human tumourigenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007
- Patterns of somatic mutation in human cancer genomesNature, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005